Read the story here. Advertise at Before It's News here.
Profile image
By IPO Scoop (Reporter)
Contributor profile | More stories
Story Views
Last hour:
Last 24 hours:

The IPO Buzz: Specialty P&C Insurer Bowhead Prices Upsized IPO at $17 – $1 Above Range

% of readers think this story is Fact. Add your two cents.

Bowhead Specialty Holdings (BOW) upsized its IPO at pricing to 7.53 million shares – up from 6.67 million shares in the prospectus – and priced the IPO at $17.00 – $1.00 above the top of its $14.00-to-$16.00 range – to raise $128.0 million on Wednesday night, May 22, 2024. Bowhead’s stock is expected to start trading today – Thursday, May 23, 2024 – on the New York Stock Exchange. J.P. Morgan, Morgan Stanley and Keefe, Bruyette & Woods acted as the joint lead book-runners. Citizens JMP, RBC Capital Markets and Dowling & Partners Securities, LLC acted as joint book-runners. Siebert Williams Shank served as co-manager. Bowhead Specialty Holdings, based in New York, provides liability insurance for the construction, distribution, heavy manufacturing, real estate and hospitality business segments; professional liability insurance for financial institutions and nonprofits, and healthcare liability insurance for hospitals, senior care providers, managed care organizations and miscellaneous medical facilities. The company was founded in 2020 during the pandemic. Bowhead says its ability to write business is “currently largely based on our relationship with AmFam,” American Family Mutual Insurance Company (AFMIC), according to the prospectus. “Through our relationship with AmFam, we are able to write business on an admitted basis in all 50 states and Washington, D.C., and on a non-admitted basis in all 50 states, Washington, D.C., and Puerto Rico.” Most of Bowhead’s business is written on a non-admitted (Excess & Surplus) basis, the prospectus says. AmFam “indirectly, owns approximately 29.0 percent of our company, as of March 31, 2024,” and it’s “also our strategic partner,”  the prospectus says. AmFam is the nation’s 12th largest P&C group by premiums with policyholder surplus of approximately $7.0 billion as of Dec. 31, 2023, the prospectus says. Bowhead is profitable. The specialty P&C insurer earned net income of $25.05 million on revenue of $283.4 million for the year that ended Dec. 31, 2023, according to financial statements in the prospectus. (For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on our website: ) Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board. To see what time the NASDAQ IPOs are expected to trade, please log in to: then scroll down to IPO Message. Disclosure: Nobody on the staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The staff does not issue advice, recommendations or opinions. Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Humic & Fulvic Liquid Trace Mineral Complex

HerbAnomic’s Humic and Fulvic Liquid Trace Mineral Complex is a revolutionary New Humic and Fulvic Acid Complex designed to support your body at the cellular level. Our product has been thoroughly tested by an ISO/IEC Certified Lab for toxins and Heavy metals as well as for trace mineral content. We KNOW we have NO lead, arsenic, mercury, aluminum etc. in our Formula. This Humic & Fulvic Liquid Trace Mineral complex has high trace levels of naturally occurring Humic and Fulvic Acids as well as high trace levels of Zinc, Iron, Magnesium, Molybdenum, Potassium and more. There is a wide range of up to 70 trace minerals which occur naturally in our Complex at varying levels. We Choose to list the 8 substances which occur in higher trace levels on our supplement panel. We don’t claim a high number of minerals as other Humic and Fulvic Supplements do and leave you to guess which elements you’ll be getting. Order Your Humic Fulvic for Your Family by Clicking on this Link , or the Banner Below.

Our Formula is an exceptional value compared to other Humic Fulvic Minerals because...


It Always Tests at 9.5+ pH

Preservative and Chemical Free

Allergen Free

Comes From a Pure, Unpolluted, Organic Source

Is an Excellent Source for Trace Minerals

Is From Whole, Prehisoric Plant Based Origin Material With Ionic Minerals and Constituents

Highly Conductive/Full of Extra Electrons

Is a Full Spectrum Complex

Our Humic and Fulvic Liquid Trace Mineral Complex has Minerals, Amino Acids, Poly Electrolytes, Phytochemicals, Polyphenols, Bioflavonoids and Trace Vitamins included with the Humic and Fulvic Acid. Our Source material is high in these constituents, where other manufacturers use inferior materials.

Try Our Humic and Fulvic Liquid Trace Mineral Complex today. Order Yours Today by Following This Link.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Load more ...




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.